Matt Dellatorre

Stock Analyst at Goldman Sachs

(2.60)
# 2,094
Out of 5,116 analysts
4
Total ratings
100%
Success rate
30.78%
Average return

Stocks Rated by Matt Dellatorre

Teva Pharmaceutical Industries
Dec 19, 2025
Maintains: Buy
Price Target: $31$35
Current: $31.89
Upside: +9.75%
Viatris
Jun 6, 2025
Initiates: Neutral
Price Target: $10
Current: $12.32
Upside: -18.83%